Related Experiment Video
Updated: Oct 5, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
438
Changes in Antihypertensive Medication Following Bariatric Surgery
Gabriel S Tajeu1, Emily Johnson2, Mason Buccilla2
1Department of Health Services Administration and Policy, College of Public Health, Temple University, Ritter Annex Suite 527, 1301 Cecil B. Moore Ave, Philadelphia, PA, 19122-6091, USA. gabriel.tajeu@temple.edu.
Obesity Surgery
|January 27, 2022
Summary
Bariatric surgery significantly reduces the need for blood pressure medication in obese patients. Many patients achieve hypertension remission and lower systolic blood pressure after procedures like Roux-en-Y gastric bypass.
Area of Science:
- Metabolic Surgery
- Cardiovascular Health
- Obesity Medicine
Background:
- Obesity is a primary driver of hypertension (high blood pressure).
- While antihypertensive medications manage blood pressure, significant weight loss offers an alternative approach.
- Surgical interventions for obesity are increasingly explored for their impact on comorbidities like hypertension.
Purpose of the Study:
- To review the impact of bariatric surgery on antihypertensive medication use and blood pressure control.
- To assess the rates of hypertension remission and blood pressure reduction following common bariatric procedures.
Main Methods:
- Systematic review of 60 articles examining antihypertensive medication use in adults undergoing bariatric surgery.
- Analysis of data focusing on Roux-en-Y gastric bypass and Laparoscopic Sleeve Gastrectomy.
- Comparison of pre- and postoperative medication usage and blood pressure readings.
Main Results:
- A significant proportion of patients discontinued antihypertensive medications post-surgery.
- The average number of antihypertensive medications decreased by approximately one.
- Hypertension remission was observed in over 75% of participants in nearly one-third of the studies.
- Systolic blood pressure decreased in almost all studies, with about 40% showing a reduction of ≥10 mm Hg.
Conclusions:
- Bariatric surgery, particularly Roux-en-Y gastric bypass and Laparoscopic Sleeve Gastrectomy, is effective in reducing antihypertensive medication needs.
- Surgical weight loss can lead to substantial improvements in blood pressure control and high rates of hypertension remission.
- These findings highlight the role of metabolic surgery in managing obesity-related hypertension.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
95
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
95
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
6
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
6
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
551
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
551
01:21Drug Dosing: Obese Patients
8
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
8
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
47
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
47
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
1.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.0K